Phase Ii study of mitolactol and semustine combination chemotherapy for advanced malignant melanoma
Creagan, E.T.; Ahmann, D.L.; Schutt, A.J.; Green, S.J.
Cancer Treatment Reports 66(6): 1425-1426
1982
ISSN/ISBN: 0361-5960 PMID: 7083244 Document Number: 189408
Twenty-six patients with disseminated malignant melanoma received an oral regimen of mitolactol and semustine (methyl-CCNU). Sixteen patients had received prior systemic therapy, and 16 had visceral involvement. There were no objective regressions among ten patients receiving the drugs as initial systemic therapy. However, one of 16 patients having prior systemic treatment did have an objective response. Hematologic and gastrointestinal toxic effects were well-tolerated.
Document emailed within 1 workday
Related Documents
Creech, R.H.; Catalano, R.B.; Dierks, K.M.; Shah, M.K. 1984: Phase Ii study of mitolactol in chemotherapy-refractory metastatic breast cancer Cancer Treatment Reports 68(12): 1499-1501Kunisaki, C.; Takahashi, M.; Nagahori, Y.; Makino, H.; Takagawa, R.; Sato, T.; Oshima, T.; Fujii, S.; Kosaka, T.; Ono, H.A.; Akiyama, H.; Shimada, H. 2008: Phase i study of biweekly docetaxel and S-1 combination chemotherapy for advanced gastric cancer Anticancer Research 28(4c): 2473-2478
Fujiwara, Y.; Fujita, J.; Kan, K.; Tsukahara, K.; Takiguchi, S.; Miyata, H.; Yasuda, T.; Doki, Y.; Monden, M. 2006: A phase i study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(1): 45-48
Beretta, G.; Bonadonna, G.; Cascinelli, N.; Morabito, A.; Veronesi, U. 1976: Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study Cancer Treatment Reports 60(1): 33-40
Ahmann, D.L.; Edmonson, J.H.; Frytak, S.; Kvols, L.K.; Bisel, H.F.; Rubin, J. 1978: Phase Ii study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma Cancer Treatment Reports 62(1): 151-153
Medina, W.; Kirkwood, J.M. 1982: Phase Ii trial of mitolactol in patients with metastatic melanoma Cancer Treatment Reports 66(1): 195-196
McClay, E.F.; Mastrangelo, M.J.; Bellet, R.E.; Berd, D. 1987: Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma Cancer Treatment Reports 71(5): 465-469
Vardi, J.R.; Tadros, G.H.; Zamurovic, D.; Rafla, S.D. 1992: Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma. Phase II Acta Obstetricia et Gynecologica Scandinavica 71(5): 361-367
Einhorn, L.H.; Furnas, B. 1977: Combination chemotherapy for disseminated malignant melanoma with DTIC, vincristine, and methyl-CCNU Cancer Treatment Reports 61(5): 881-883
Ikeda, S.; Ishihara, K.; Taguchi, G. 1985: Phase IIi study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(1): 77-85
Hoffman, P.C.; Masters, G.A.; Drinkard, L.C.; Krauss, S.A.; Samuels, B.L.; Golomb, H.M.; Vokes, E.E. 1996: Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies Seminars in Oncology 23(3 Suppl 6: 11-15
Carmo-Pereira, J.; Costa, F.O.; Pimentel, P.; Henriques, E. 1980: Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup Cancer Treatment Reports 64(1): 143-145
Klener, P.; Donner, L.; Roth, Z. 1976: Chemotherapy of advanced malignant lymphomas comparative evaluation of results with single agent and combination therapy Neoplasma 23(3): 315-322
Matsukado, Y.; Abe, H.; Tanaka, R.; Kobayashi, T.; Yamashita, J.; Nishimoto, A.; Ushio, Y.; Sato, K.; Matsutani, M.; Takakura, K. 1986: Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a phase II study--The Japanese Intracranial Germ Cell Tumor Study Group Gan No Rinsho. Japan Journal of Cancer Clinics 32(11): 1387-1393
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Fujiwara, Y.; Taniguchi, H.; Kimura, Y.; Takiguchi, S.; Yasuda, T.; Yano, M.; Monden, M. 2003: Two advanced gastric cancer patients who showed malignant ileus soon after administration of combination therapy of preoperative intra-peritoneal chemotherapy and gastrectomy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(11): 1614-1617
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Kurtz, J-Emmanuel.; Négrier, S.; Husseini, F.; Limacher, J-Marc.; Borel, C.; Wagner, J-Philippe.; Prévot, G.; Bergerat, J-Pierre.; Dufour, P. 2003: A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer Hepato-Gastroenterology 50(50): 567-570
Creagan, E.T.; Ahmann, D.L.; Long, H.J.; Frytak, S.; Sherwin, S.A.; Chang, M.N. 1987: Phase Ii study of recombinant interferon-gamma in patients with disseminated malignant melanoma Cancer Treatment Reports 71(9): 843-844
Thigpen, J.T.; Al-Sarraf, M.; Hewlett, J.S. 1979: Phase Ii trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study Cancer Treatment Reports 63(4): 525-528